Fig. 3From: The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysisSurvival curves for those aged up to and beyond 65 years of age. The median survival is not reached in both groups (p 0.0875)Back to article page